Perrigo (PRGO) Assets Average (2013 - 2026)
Perrigo's (PRGO) quarterly Assets Average came in at $8.3 billion in Q1 2026, down 14.89% year-on-year from $9.7 billion in Q1 2025, and down 11.28% on a QoQ basis from $9.3 billion in Q4 2025.
Perrigo (PRGO) Assets Average (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Assets Average data on file, last reported at $8.3 billion in Q1 2026.
- On a quarterly basis, Assets Average fell 14.89% year-over-year to $8.3 billion in Q1 2026; TTM through Mar 2026 was $8.3 billion, a 14.89% decrease from a year earlier, with the FY2025 full-year figure at $9.1 billion, down 11.12% from the prior year.
- Assets Average for Q1 2026 stood at $8.3 billion, down from $9.3 billion in the prior quarter.
- Over the last five years, Assets Average for PRGO reached as high as $11.0 billion in Q2 2023 and fell as low as $8.3 billion in Q1 2026.
- Historically, Assets Average has averaged $10.4 billion across 5 years, with a median of $10.7 billion in 2022.
- Across the five-year window, Assets Average climbed 5.56% in 2023 and dropped 14.89% in 2026, its largest moves.
- Year by year, Assets Average stood at $10.8 billion in 2022, then declined by 0.59% to $10.8 billion in 2023, then fell by 3.32% to $10.4 billion in 2024, then declined by 10.7% to $9.3 billion in 2025, then dropped by 11.28% to $8.3 billion in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $8.3 billion in Q1 2026, $9.3 billion in Q4 2025, and $10.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | 8.26 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 8.26 Bn |
| Dec 31, 2025 | 9.31 Bn |
| Sep 27, 2025 | 10.09 Bn |
| Jun 28, 2025 | 9.93 Bn |
| Mar 29, 2025 | 9.70 Bn |
| Dec 31, 2024 | 10.43 Bn |
| Sep 28, 2024 | 10.80 Bn |
| Jun 29, 2024 | 10.52 Bn |
| Mar 30, 2024 | 10.72 Bn |
| Dec 31, 2023 | 10.78 Bn |
| Sep 30, 2023 | 10.86 Bn |
| Jul 1, 2023 | 10.96 Bn |
| Apr 1, 2023 | 10.99 Bn |
| Dec 31, 2022 | 10.85 Bn |
| Oct 1, 2022 | 10.80 Bn |
| Jul 2, 2022 | 10.65 Bn |
| Apr 2, 2022 | 10.41 Bn |
| Dec 31, 2021 | 10.67 Bn |
| Oct 2, 2021 | 11.07 Bn |
| Jul 3, 2021 | 11.28 Bn |